LINCOLN — LINCOLN PHARMACEUTICALS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for LINCOLN PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	235	464	922	1,153	1,138
Net Total Accounts Receivable
Net Total Receivables	1,456	1,335	1,464	1,513	1,637
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,240	2,480	3,065	3,528	3,672
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,134	1,132	1,119	1,476	1,569
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3,660	3,894	4,594	5,344	5,874
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	853	656	735	905	723
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	966	763	841	1,015	849
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,693	3,131	3,753	4,329	5,025
Total Liabilities & Shareholders' Equity	3,660	3,894	4,594	5,344	5,874
Total Common Shares Outstanding